Cancer News
Newest HER2-Targeted Therapy No Better Than Original Agent

EU Thumbs Up for Bortezomib for Mantle Cell Lymphoma

FDA Approves Olaparib (Lynparza) for BRCA Ovarian Cancer

First-ever ASCO Partnership With Pathologists

The Year in Gynecologic Cancer: Bevacizumab and Beyond
When RNA-binding proteins are turned on, cancer cells get locked in a proliferative state

Ways to prevent and manage jaw bone disease highlighted

Signaling mechanism could be target for survival, growth of tumor cells in brain cancer

Cancer genes contribute to congenital disorders

Researchers shed light on how diet influences cancer development
FDA Approves First in New Class of Drugs for Advanced Ovarian Cancer

Crohn's, Colitis May Have Genetic Underpinnings, Study Finds

Cancer Treatment Costs Weigh Heavily on Patients, Study Finds

E-Cigarettes Less Addictive Than Regular Cigarettes, Study Finds

Global Life Expectancy Continues to Climb
UCLA Cancer Researcher Named Fellow of the National Academy of Inventors

New Study Finds Promising Drug Doubled Positive Effect in Hormone-Receptor Positive Breast Cancer

FDA Approves Drug that Extends Survival in the Most Common Type of Lung Cancer

UCLA Researcher Advances Robotic Surgery Technique to Treat Previously Inoperable Head and Neck Cancer Tumors

JCCC Scientist Honored with Prestigious Biomedical Research Award
Phase III study on efficacy of taxanes plus bevacizumab with or without capecitabine as first-line chemotherapy in metastatic breast cancer

Obesity-associated systemic interleukin-6 promotes pre-adipocyte aromatase expression via increased breast cancer cell prostaglandin E2 production

Risk of subsequent cutaneous malignancy in patients with prior melanoma: a systematic review and meta-analysis

Polymorphism of DNA methyltransferase 3B -149C/T and cancer risk: A meta-analysis

The value of serum Cyfra21-1 as a biomarker in the diagnosis of patients with non-small cell lung cancer: A meta-analysis